Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers


  Liver Diseases

  Free Subscription

Articles published in Cancer Res

Retrieve available abstracts of 78 articles:
HTML format

Single Articles

    April 2020
  1. ZHANG L, Huo Q, Ge C, Zhao F, et al
    ZNF143-mediated H3K9 trimethylation upregulates CDC6 by activating MDIG in hepatocellular carcinoma.
    Cancer Res. 2020 Apr 20. pii: 0008-5472.CAN-19-3226.
    PubMed     Abstract available

    March 2020
  2. ZHU H, Yan F, Yuan T, Qian M, et al
    USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP/TAZ.
    Cancer Res. 2020 Mar 26. pii: 0008-5472.CAN-19-2388.
    PubMed     Abstract available

    February 2020
  3. GRAMANTIERI L, Pollutri D, Gagliardi M, Giovannini C, et al
    MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma.
    Cancer Res. 2020 Feb 3. pii: 0008-5472.CAN-19-0472.
    PubMed     Abstract available

    January 2020
  4. LIAO K, Deng S, Xu L, Pan W, et al
    A Feedback Circuitry between Polycomb Signaling and Fructose-1, 6-Bisphosphatase Enables Hepatic and Renal Tumorigenesis.
    Cancer Res. 2020 Jan 16. pii: 0008-5472.CAN-19-2060.
    PubMed     Abstract available

    December 2019
  5. WU Y, Zhao YM, Huan L, Zhao J, et al
    A LTR retrotransposon-derived long non-coding RNA lncMER52A promotes hepatocellular carcinoma progression by binding p120-catenin.
    Cancer Res. 2019 Dec 24. pii: 0008-5472.CAN-19-2115.
    PubMed     Abstract available

    November 2019
  6. MATTHEW-ONABANJO AN, Janusis J, Mercado-Matos J, Carlisle AE, et al
    Beclin 1 promotes endosome recruitment of hepatocyte growth factor tyrosine kinase substrate (HRS) to suppress tumor proliferation.
    Cancer Res. 2019 Nov 19. pii: 0008-5472.CAN-19-1555.
    PubMed     Abstract available

  7. YARCHOAN M, Agarwal P, Villanueva A, Rao S, et al
    Correction: Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma.
    Cancer Res. 2019;79:5897.

  8. DAUKI AM, Blachly JS, Kautto EA, Ezzat S, et al
    Transcriptionally Active Androgen Receptor Splice Variants Promote Hepatocellular Carcinoma Progression.
    Cancer Res. 2019 Nov 4. pii: 0008-5472.CAN-19-1117.
    PubMed     Abstract available

    October 2019
  9. FEKRY B, Ribas Latre A, Baumgartner C, Mohamed AMT, et al
    HNF4alpha-deficient Fatty Liver Provides a Permissive Environment for Sex-independent Hepatocellular Carcinoma.
    Cancer Res. 2019 Oct 1. pii: 0008-5472.CAN-19-1277.
    PubMed     Abstract available

    September 2019
  10. JEE BA, Choi JH, Rhee H, Yoon S, et al
    Dynamics of genomic, epigenomic, and transcriptomic aberrations during stepwise hepatocarcinogenesis.
    Cancer Res. 2019 Sep 10. pii: 0008-5472.CAN-19-0991.
    PubMed     Abstract available

  11. YARCHOAN M, Agarwal P, Villanueva A, Rao S, et al
    Recent Developments and Therapeutic Strategies against Hepatocellular Carcinoma.
    Cancer Res. 2019;79:4326-4330.
    PubMed     Abstract available

    August 2019
  12. XU M, Wang J, Xu Z, Li R, et al
    SNAI1 promotes the cholangiocellular phenotype, but not epithelial-mesenchymal transition, in a murine hepatocellular carcinoma model.
    Cancer Res. 2019 Aug 5. pii: 0008-5472.CAN-18-3750.
    PubMed     Abstract available

    July 2019
  13. LIM LJ, Wong SYS, Huang F, Lim S, et al
    Roles and Regulation of Long non-coding RNAs in Hepatocellular Carcinoma.
    Cancer Res. 2019 Jul 23. pii: 0008-5472.CAN-19-0255.
    PubMed     Abstract available

  14. ZHANG H, Xing S, Li Z, Ma W, et al
    DIS3L2 promotes progression of hepatocellular carcinoma via hnRNP U-mediated alternative splicing.
    Cancer Res. 2019 Jul 22. pii: 0008-5472.CAN-19-0376.
    PubMed     Abstract available

  15. YOON AR, Hong J, Li Y, Shin HC, et al
    Mesenchymal stem cell-mediated delivery of an oncolytic adenovirus enhances antitumor efficacy in hepatocellular carcinoma.
    Cancer Res. 2019 Jul 9. pii: 0008-5472.CAN-18-3900.
    PubMed     Abstract available

  16. YE YC, Zhao JL, Lu YT, Gao CC, et al
    Notch signaling via Wnt regulates the proliferation of alternative, CCR2-independent tumor-associated macrophages in hepatocellular carcinoma.
    Cancer Res. 2019 Jul 2. pii: 0008-5472.CAN-18-1691.
    PubMed     Abstract available

    June 2019
  17. WONG BS, Shea DJ, Mistriotis P, Tuntithavornwat S, et al
    A Direct Podocalyxin-Dynamin-2 Interaction Regulates Cytoskeletal Dynamics to Promote Migration and Metastasis in Pancreatic Cancer Cells.
    Cancer Res. 2019;79:2878-2891.
    PubMed     Abstract available

    May 2019
  18. LAN T, Yuan K, Yan X, Xu L, et al
    LncRNA SNHG10 facilitates hepatocarcinogenesis and metastasis by modulating its homolog SCARNA13 via a positive feedback loop.
    Cancer Res. 2019 May 17. pii: 0008-5472.CAN-18-4044.
    PubMed     Abstract available

  19. MALAKAR P, Stein I, Saragovi A, Winkler R, et al
    Long Noncoding RNA MALAT1 Regulates Cancer Glucose Metabolism by Enhancing mTOR-Mediated Translation of TCF7L2.
    Cancer Res. 2019;79:2480-2493.
    PubMed     Abstract available

  20. GORDON JA, Noble JW, Midha A, Derakhshan F, et al
    Upregulation of Scavenger receptor B1 is required for steroidogenic and non-steroidogenic cholesterol metabolism in prostate cancer.
    Cancer Res. 2019 May 7. pii: 0008-5472.CAN-18-2529.
    PubMed     Abstract available

  21. ZHANG G, Li X, Chen Q, Li J, et al
    CD317 Activates EGFR by Regulating Its Association with Lipid Rafts.
    Cancer Res. 2019;79:2220-2231.
    PubMed     Abstract available

    March 2019
  22. SUN F, Wang Y, Luo X, Ma Z, et al
    Anti-CD24 antibody-nitric oxide conjugate (ANC) selectively and potently suppresses hepatic carcinoma.
    Cancer Res. 2019 Mar 27. pii: 0008-5472.CAN-18-2839.
    PubMed     Abstract available

  23. AMBROSINI G, Do C, Tycko B, Realubit RB, et al
    Inhibition of NF-kappaB-dependent signaling enhances sensitivity and overcomes resistance to BET inhibition in uveal melanoma.
    Cancer Res. 2019 Mar 18. pii: 0008-5472.CAN-18-3177.
    PubMed     Abstract available

  24. LILLO OSUNA MA, Garcia-Lopez J, El Ayachi I, Fatima I, et al
    Activation of Estrogen Receptor Alpha by Decitabine Inhibits Osteosarcoma Growth and Metastasis.
    Cancer Res. 2019;79:1054-1068.
    PubMed     Abstract available

  25. TAKAI A, Dang H, Oishi N, Khatib S, et al
    Genome-wide RNAi Screen identifies PMPCB as a therapeutic vulnerability in EpCAM+ hepatocellular carcinoma.
    Cancer Res. 2019 Mar 12. pii: 0008-5472.CAN-18-3015.
    PubMed     Abstract available

  26. FEKIR K, Dubois-Pot-Schneider H, Desert R, Daniel Y, et al
    Retrodifferentiation of human tumor hepatocytes to stem cells leads to metabolic reprogramming and chemoresistance.
    Cancer Res. 2019 Mar 5. pii: 0008-5472.CAN-18-2110.
    PubMed     Abstract available

    February 2019
  27. KWEE SA, Tiirikainen M, Sato MM, Acoba JD, et al
    Transcriptomics associates molecular features with 18F-fluorocholine PET/CT imaging phenotype and its potential relationship to survival in hepatocellular carcinoma.
    Cancer Res. 2019 Feb 13. pii: 0008-5472.CAN-18-3837.
    PubMed     Abstract available

  28. HAN J, Meng J, Wang X, Yin S, et al
    YY1 complex promotes Quaking expression via super-enhancer binding during EMT of hepatocellular carcinoma.
    Cancer Res. 2019 Feb 13. pii: 0008-5472.CAN-18-2238.
    PubMed     Abstract available

  29. XU F, Li CH, Wong CH, Chen GG, et al
    Genome-wide screening and functional analysis identifies tumor suppressor long non-coding RNAs epigenetically silenced in hepatocellular carcinoma.
    Cancer Res. 2019 Feb 4. pii: 0008-5472.CAN-18-1659.
    PubMed     Abstract available

  30. OSHIMA G, Poli EC, Bolt MJ, Chlenski A, et al
    DNA Methylation Controls Metastasis-Suppressive 14q32-Encoded miRNAs.
    Cancer Res. 2019;79:650-662.
    PubMed     Abstract available

    December 2018
  31. CHEN SL, Zhang CZ, Liu LL, Lu SX, et al
    A GYS2/p53 negative feedback loop restricts tumor growth in HBV-related hepatocellular carcinoma.
    Cancer Res. 2018 Dec 24. pii: 0008-5472.CAN-18-2357.
    PubMed     Abstract available

  32. DONG Q, Du Y, Li H, Liu C, et al
    EGFR and c-MET cooperate to enhance resistance to PARP inhibitors in hepatocellular carcinoma.
    Cancer Res. 2018 Dec 20. pii: 0008-5472.CAN-18-1273.
    PubMed     Abstract available

  33. WOHLFEIL SA, Hafele V, Dietsch B, Schledzewski K, et al
    Hepatic endothelial Notch activation protects against liver metastasis by regulating endothelial-tumor cell adhesion independent of angiocrine signaling.
    Cancer Res. 2018 Dec 10. pii: 0008-5472.CAN-18-1752.
    PubMed     Abstract available

  34. GU Y, Wei X, Sun Y, Gao H, et al
    miR-192-5p silencing by genetic aberrations is a key event in hepatocellular carcinomas with cancer stem cell features.
    Cancer Res. 2018 Dec 7. pii: 0008-5472.CAN-18-1675.
    PubMed     Abstract available

    November 2018
  35. PENG L, Jiang B, Yuan X, Qiu Y, et al
    Super-enhancer-associated long non-coding RNA HCCL5 is activated by ZEB1 and promotes the malignancy of hepatocellular carcinoma.
    Cancer Res. 2018 Nov 27. pii: 0008-5472.CAN-18-0367.
    PubMed     Abstract available

    October 2018

  36. Correction: Telomerase-dependent Virotherapy Overcomes Resistance of Hepatocellular Carcinomas against Chemotherapy and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand by Elimination of Mcl-1.
    Cancer Res. 2018;78:6026.

    September 2018
  37. LIANG J, Chen M, Hughes D, Chumanevich AA, et al
    CDK8 selectively promotes the growth of colon cancer metastases in the liver by regulating gene expression of TIMP3 and matrix metalloproteinases.
    Cancer Res. 2018 Sep 5. pii: 0008-5472.CAN-18-1583.
    PubMed     Abstract available

  38. ROBERTSON CL, Mendoza RG, Jariwala N, Dozmorov M, et al
    Astrocyte elevated gene-1 (AEG-1) regulates macrophage activation in hepatocellular carcinogenesis.
    Cancer Res. 2018 Sep 4. pii: 0008-5472.CAN-18-0659.
    PubMed     Abstract available

    August 2018
  39. GU L, Zhu Y, Lin X, Li Y, et al
    Amplification of glyceronephosphate O-acyltransferase and recruitment of USP30 stabilize DRP1 to promote hepatocarcinogenesis.
    Cancer Res. 2018 Aug 24. pii: 0008-5472.CAN-18-0340.
    PubMed     Abstract available

    July 2018
  40. YAO Y, Sun S, Wang J, Fei F, et al
    Canonical Wnt signaling remodels lipid metabolism in zebrafish hepatocytes following Ras oncogenic insult.
    Cancer Res. 2018 Jul 31. pii: 0008-5472.CAN-17-3964.
    PubMed     Abstract available

  41. MAKINO Y, Hikita H, Kodama T, Shigekawa M, et al
    CTGF mediates tumor-stroma interactions between hepatoma cells and hepatic stellate cells to accelerate HCC progression.
    Cancer Res. 2018 Jul 2. pii: 0008-5472.CAN-17-3844.
    PubMed     Abstract available

  42. LI Y, Lin S, Li L, Tang Z, et al
    PDSS2 deficiency induces hepatocarcinogenesis by decreasing mitochondrial respiration and reprogramming glucose metabolism.
    Cancer Res. 2018 Jul 2. pii: 0008-5472.CAN-17-2172.
    PubMed     Abstract available

    June 2018
  43. QI LN, Xiang BD, Wu FX, Ye JZ, et al
    Circulating tumor cells undergoing EMT provide a metric for diagnosis and prognosis of patients with hepatocellular carcinoma.
    Cancer Res. 2018 Jun 18. pii: 0008-5472.CAN-17-2459.
    PubMed     Abstract available

  44. Retraction: Identification of Brain-Derived Neurotrophic Factor as a Novel Functional Protein in Hepatocellular Carcinoma.
    Cancer Res. 2018;78:3400.

  45. Retraction: The Potential Role of Hypoxia Inducible Factor 1alpha in Tumor Progression after Hypoxia and Chemotherapy in Hepatocellular Carcinoma.
    Cancer Res. 2018;78:3399.

  46. HILL MA, Alexander WB, Guo B, Kato Y, et al
    Kras and Tp53 mutations cause cholangiocyte- and hepatocyte-derived cholangiocarcinoma.
    Cancer Res. 2018 Jun 5. pii: 0008-5472.CAN-17-1123.
    PubMed     Abstract available

    May 2018
  47. MENG J, Chen S, Han J, Qian B, et al
    Twist1 regulates Vimentin through Cul2 circular RNA to promote EMT in hepatocellular carcinoma.
    Cancer Res. 2018 May 29. pii: 0008-5472.CAN-17-3009.
    PubMed     Abstract available

  48. WEN LZ, Ding K, Wang ZR, Ding CH, et al
    SHP-1 acts as a Tumor Suppressor in Hepatocarcinogenesis and HCC Progression.
    Cancer Res. 2018 May 18. pii: 0008-5472.CAN-17-3896.
    PubMed     Abstract available

    March 2018
  49. XU J, Yang Y, Xie R, Liu J, et al
    The NCX1/TRPC6 complex mediates TGFbeta-driven migration and invasion of human hepatocellular carcinoma cells.
    Cancer Res. 2018 Mar 2. pii: 0008-5472.CAN-17-2061.
    PubMed     Abstract available

  50. SAKAI E, Nakayama M, Oshima H, Kouyama Y, et al
    Combined Mutation of Apc, Kras, and Tgfbr2 Effectively Drives Metastasis of Intestinal Cancer.
    Cancer Res. 2018;78:1334-1346.
    PubMed     Abstract available

  51. VERZELLA D, Bennett J, Fischietti M, Thotakura AK, et al
    GADD45beta Loss Ablates Innate Immunosuppression in Cancer.
    Cancer Res. 2018;78:1275-1292.
    PubMed     Abstract available

    February 2018
  52. CAI Z, Qian ZY, Jiang H, Ma N, et al
    hPCL3s promotes hepatocellular carcinoma metastasis by activating beta-catenin signaling.
    Cancer Res. 2018 Feb 26. pii: 0008-5472.CAN-17-0028.
    PubMed     Abstract available

  53. CHENG BY, Lau EY, Leung HW, Leung CO, et al
    IRAK1 augments cancer stemness and drug resistance via the AP-1/AKR1B10 signaling cascade in hepatocellular carcinoma.
    Cancer Res. 2018 Feb 26. pii: 0008-5472.CAN-17-2445.
    PubMed     Abstract available

  54. LIU C, Liu L, Chen X, Cheng J, et al
    LSD1 Stimulates Cancer-Associated Fibroblasts to Drive Notch3-Dependent Self-Renewal of Liver Cancer Stem-like Cells.
    Cancer Res. 2018;78:938-949.
    PubMed     Abstract available

  55. ZHANG YL, Li Q, Yang XM, Fang F, et al
    SPON2 Promotes M1-like Macrophage Recruitment and Inhibits Hepatocellular Carcinoma Metastasis by Distinct Integrin-Rho GTPase-Hippo Pathways.
    Cancer Res. 2018 Feb 13. pii: 0008-5472.CAN-17-2867.
    PubMed     Abstract available

  56. KOHLI S, Bhardwaj A, Kumari R, Das S, et al
    SIRT6 Is a Target of Regulation by UBE3A That Contributes to Liver Tumorigenesis in an ANXA2-Dependent Manner.
    Cancer Res. 2018;78:645-658.
    PubMed     Abstract available

    January 2018
  57. RHEE H, Kim HY, Choi JH, Woo HG, et al
    Keratin 19 expression in hepatocellular carcinoma is regulated by fibroblast-derived HGF via a MET-ERK1/2-AP1 and SP1 axis.
    Cancer Res. 2018 Jan 23. pii: 0008-5472.CAN-17-0988.
    PubMed     Abstract available

  58. SHEN J, Li P, Shao X, Yang Y, et al
    The E3 Ligase RING1 Targets p53 for Degradation and Promotes Cancer Cell Proliferation and Survival.
    Cancer Res. 2018;78:359-371.
    PubMed     Abstract available

    December 2017
  59. JOSHI JJ, Coffey H, Corcoran E, Tsai J, et al
    H3B-6527 Is a Potent and Selective Inhibitor of FGFR4 in FGF19-Driven Hepatocellular Carcinoma.
    Cancer Res. 2017;77:6999-7013.
    PubMed     Abstract available

    November 2017
  60. YAN Q, Jiang L, Liu M, Yu D, et al
    ANGPTL1 Interacts with Integrin alpha1beta1 to Suppress HCC Angiogenesis and Metastasis by Inhibiting JAK2/STAT3 Signaling.
    Cancer Res. 2017;77:5831-5845.
    PubMed     Abstract available

  61. D'COSTA Z, Jones K, Azad A, van Stiphout R, et al
    Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer.
    Cancer Res. 2017;77:5952-5962.
    PubMed     Abstract available

    October 2017
  62. ZHANG CZ, Chen SL, Wang CH, He YF, et al
    CBX8 exhibits oncogenic activity via AKT/beta-Catenin activation in hepatocellular carcinoma.
    Cancer Res. 2017 Oct 24. pii: canres.0700.2017.
    PubMed     Abstract available

  63. TSCHIDA BR, Temiz NA, Kuka TP, Lee LA, et al
    Sleeping Beauty insertional mutagenesis in mice identifies drivers of steatosis-associated hepatic tumor.
    Cancer Res. 2017 Oct 9. pii: canres.2281.2017.
    PubMed     Abstract available

    September 2017
  64. MATSUMOTO T, Takai A, Eso Y, Kinoshita K, et al
    Proliferating EpCAM-positive ductal cells in the inflamed liver give rise to hepatocellular carcinoma.
    Cancer Res. 2017 Sep 26. pii: canres.1800.2017.
    PubMed     Abstract available

  65. TENG Y, Zhao H, Gao L, Zhang W, et al
    FGF19 protects hepatocellular carcinoma cells against endoplasmic reticulum stress via activation of FGFR4-GSK3beta-Nrf2 signaling.
    Cancer Res. 2017 Sep 26. pii: canres.2039.2017.
    PubMed     Abstract available

  66. YAN X, Zhang D, Wu W, Wu S, et al
    Mesenchymal stem cells promote hepatocarcinogenesis via lncRNA-MUF interaction with ANXA2 and miR-34a.
    Cancer Res. 2017 Sep 25. pii: canres.1915.2017.
    PubMed     Abstract available

    August 2017
  67. MENDEZ-LUCAS A, Li X, Hu J, Che L, et al
    Glucose Catabolism in Liver Tumors Induced by c-MYC Can Be Sustained by Various PKM1/PKM2 Ratios and Pyruvate Kinase Activities.
    Cancer Res. 2017;77:4355-4364.
    PubMed     Abstract available

  68. YE J, Li TS, Xu G, Zhao YM, et al
    JCAD Promotes Progression of Non-alcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity.
    Cancer Res. 2017 Aug 3. pii: canres.0229.2017.
    PubMed     Abstract available

  69. WANG LT, Chiou SS, Chai CY, Hsi E, et al
    Intestine-Specific Homeobox Gene ISX Integrates IL6 Signaling, Tryptophan Catabolism, and Immune Suppression.
    Cancer Res. 2017;77:4065-4077.
    PubMed     Abstract available

    July 2017
  70. TILL J, Yoon C, Kim BJ, Roby KC, et al
    Oncogenic KRAS and p53 loss drive gastric tumorigenesis in mice that can be attenuated by E-cadherin expression.
    Cancer Res. 2017 Jul 31. pii: canres.0061.2017.
    PubMed     Abstract available

  71. NG KY, Chan LH, Chai S, Tong M, et al
    TP53INP1 down-regulation activates a p73-dependent DUSP10/ERK signaling pathway to promote metastasis of hepatocellular carcinoma.
    Cancer Res. 2017 Jul 3. pii: canres.3456.2016.
    PubMed     Abstract available

  72. BARBAZAN J, Alonso-Alconada L, Elkhatib N, Geraldo S, et al
    Liver Metastasis Is Facilitated by the Adherence of Circulating Tumor Cells to Vascular Fibronectin Deposits.
    Cancer Res. 2017;77:3431-3441.
    PubMed     Abstract available

    June 2017
  73. NGO HKC, Kim DH, Cha YN, Na HK, et al
    Nrf2 mutagenic activation drives hepatocarcinogenesis.
    Cancer Res. 2017 Jun 27. pii: canres.3538.2016.
    PubMed     Abstract available

  74. AKIEL M, Guo C, Li X, Rajasekaran D, et al
    IGFBP7 Deletion Promotes Hepatocellular Carcinoma.
    Cancer Res. 2017 Jun 15. pii: canres.2885.2016.
    PubMed     Abstract available

    April 2017
  75. WANG D, Sun H, Wei J, Cen B, et al
    CXCL1 is critical for pre-metastatic niche formation and metastasis in colorectal cancer.
    Cancer Res. 2017 Apr 28. pii: canres.3199.2016.
    PubMed     Abstract available

  76. JARIWALA N, Rajasekaran D, Mendoza RG, Shen XN, et al
    Oncogenic Role of SND1 in Development and Progression of Hepatocellular Carcinoma.
    Cancer Res. 2017 Apr 20. pii: canres.0298.2017.
    PubMed     Abstract available

  77. YUE F, Li W, Zou J, Jiang X, et al
    Spermidine prolongs lifespan and prevents liver fibrosis and hepatocellular carcinoma by activating MAP1S-mediated autophagy.
    Cancer Res. 2017 Apr 6. pii: canres.3462.2016.
    PubMed     Abstract available

    March 2017
  78. QIAO G, Qin J, Kunda N, Calata J, et al
    LIGHT elevation enhances immune eradication of colon cancer metastases.
    Cancer Res. 2017 Mar 1. pii: canres.1655.2016.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.